Tag Archives: immunotherapy

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of NSCLC

Due to the distinct features of cancer immunotherapy, and rapid progress in the field, clinical guidance is needed on the use of these agents, including appropriate patient selection, sequencing of therapies, response monitoring, adverse event management, and biomarker testing. The Society for Immunotherapy of Cancer (SITC) convened an expert Task Force charged with developing consensus recommendations on these key issues. […]

Read More

LuCE at ASCO 2018 – Lung cancer highlights

Prof. Giulio Scagliotti talked about lungcancer highlights with Stefania Vallone, LuCE president and Diego Villalón, LuCE member. Topics focused on new treatment for scuamous cell carcinoma and combination of imunotherapy and chemotherapy for a large number of PDL-1 patients.

Read More

LuCE at ASCO 2018 – Lung cancer screening

LuCE members Walce Onlus & Fundacion Mas Que Ideas attended the American Society of Clinical Oncology (ASCO) Annual Meeting. They talked with MD Paolo Bironzo about the topics on immunotherapy in lung cancer presented at ASCO 2018. Check out here the interview https://t.co/vg13smrVYS

Read More

Treatments and Clinical Trials

Treatments (chemo, radio, surgery, TT, I-O) In most hospitals, a team of specialists will plan the treatment they feel is best for your individual situation. This multidisciplinary team of medical professionals may include: A surgeon. A medical oncologist(a doctor who specialises in the medical management of cancer). A radiation oncologist. A chest physician. A nurse […]

Read More